Key result
Multiple myeloma carried the highest 1-year MI risk vs low-risk skin tumors, though absolute risk remained <1% across all 13 cancer subtypes.
Why the study?
Does the one-year risk of myocardial infarction vary across 13 different cancer subtypes compared with low-risk skin tumors in patients without prior coronary artery disease?
Cohort (n=660,531)
Yes
Does the one-year risk of myocardial infarction vary across 13 different cancer subtypes compared with low-risk skin tumors in patients without prior coronary artery disease?
While one-year relative risk of myocardial infarction is significantly elevated in several cancers—particularly multiple myeloma, bladder, kidney, leukemia, and GI cancers—standardized absolute one-year MI risk remains below 1% across all subtypes amidst substantial competing all-cause mortality.
Answers are grounded in this paper and cite their sources.
Low absolute MI risks limit clinical utility of subtype-specific stratification; leaves open whether targeted prevention reduces events in higher-RR cancers.
As cancer survival improves, a growing population of patients is exposed to elevated cardiovascular risk. We compared the one-year risk of myocardial infarction (MI) across 13 cancer types using patients with low-risk skin tumors as a cancer-active reference group. In this nationwide registry-based cohort study, we included 660,531 Danish patients diagnosed with one of 13 cancer subtypes between 2000 and 2023. Patients with prior MI or coronary revascularization were excluded. Standardized one-year absolute risks of MI were estimated using the Aalen-Johansen estimator with inverse probability of treatment weighting, while relative risks were estimated using g-computation based on cause-specific Cox models for MI and all-cause death. Compared with patients with low-risk skin tumors, the relative risk of MI was highest in multiple myeloma (RR 1.80, 95% CI 1.34-2.26), bladder cancer (RR 1.52, 95% CI 1.26-1.78), kidney cancer (RR 1.51, 95% CI 1.20-1.82), leukemia (RR 1.45, 95% CI 1.16-1.75), and gastrointestinal cancer (RR 1.37, 95% CI 1.24-1.50). Standardized one-year MI risk remained below 1% across all cancer subtypes, ranging from 0.31% in breast cancer to 0.91% in multiple myeloma. One-year all-cause mortality varied markedly across cancer subtypes, from 2.2% in patients with low-risk skin tumors to 71.9% in patients with hepatobiliary and pancreatic cancer. One-year MI risk varied across cancer subtypes. Relative and standardized absolute MI risks were highest in patients with multiple myeloma, with increased risks also observed in several other cancer subtypes. These findings represent MI risk in the presence of substantial competing mortality and should not be interpreted as differences in underlying biological susceptibility to MI.
No takes yet. Share an insight, caveat, or question.
Shanmuganathan et al. (2026) conducted a cohort in Patients diagnosed with one of 13 cancer subtypes (n=660,531). Diagnosis across 13 cancer subtypes (highest risk in multiple myeloma) vs. Patients with low-risk skin tumors (cancer-active reference group) was evaluated on One-year risk of myocardial infarction (MI) (RR 1.80, 95% CI 1.34-2.26). Multiple myeloma carried the highest 1-year MI risk vs low-risk skin tumors, though absolute risk remained <1% across all 13 cancer subtypes.
Synapse has enriched 10 related papers. Consider them for comparative context: